IRTC insider trading
NasdaqGS HealthcareiRhythm Holdings, Inc.: insider trade history from SEC Form 4 filings.
About iRhythm Holdings, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within our ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Company website: www.irhythmtech.com
IRTC insider activity at a glance
FilingIQ tracks 846 insider transactions for IRTC in filings since Oct 25, 2016. The most recent transaction is dated Sep 2, 2026.
Across the full history, 7 open-market purchases
and 442 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on IRTC insider trades is 61.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest IRTC Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for IRTC?
- FilingIQ tracks 846 Form 4 insider transactions for IRTC (iRhythm Holdings, Inc.), covering filings from Oct 25, 2016 onwards. 14 of those are dated within the last 90 days.
- Are IRTC insiders net buyers or net sellers?
- Across the full Form 4 history for IRTC, 7 transactions (1%) were open-market purchases and 442 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does IRTC insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is IRTC in?
- iRhythm Holdings, Inc. (IRTC) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $4.49B.
Methodology & sources
Every IRTC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.